期刊文献+

伴有5号染色体长臂缺失的急性淋巴细胞白血病一例并文献复习 被引量:1

One case of acute lymphoblastic leukemia with del(5q) and literatures review
原文传递
导出
摘要 目的探讨伴有5号染色体长臂缺失(5q-)的急性淋巴细胞白血病的临床及实验室特点。方法报道1例伴有5q一的急性淋巴细胞白血病,并对相关文献进行复习。结果患者因腹痛、骨痛就诊。血常规显示白细胞增高、血小板减少。经骨髓穿刺、过氧化物酶染色、流式细胞术免疫分型检测,诊断为急性淋巴细胞白血病(前T细胞型)。染色体及荧光免疫杂交检测均发现5q-。应用hyper—CVAD方案化疗曾短暂缓解,复发后应用MEA和hyper—CVAD方案,均无效。通过文献复习发现,5q-在急性淋巴细胞白血病中十分罕见,此类患者5q缺失序列的最小重叠范围位于DNA标记D5S410和D5S436之间,即5q31.33区域。结论急性淋巴细胞白血病中5q-相当罕见,对该类疾病特点仍需进一步研究。 Objective To introduce the laboratory and clinical characteristics of acute lymphoblastic leukemia accompanied by the karyotypic abnormality of 5q-. Methods Report the diagnosis and treatment of one case of acute lymphoblastie leukemia with 5 q- and review the relevant literatures. Results The patient came to the hospital because of bellyache and ostalgia.The blood routine showed a high WBC count and reduced platelets.Bone marrow aspirates examination indicated acute leukemia and by peroxidase staining and flow eytometry test,acute pro-T lymphoblastic leukemia was diagnosed. The karyotype and fluorescence in situ hybridization analysis showed 5q-. The hyper-CVAD regimen induced a temporary remission but it did not work anymore after the relapse nor did the MEA regimen. From the literatures ever reported, the kyryotypic abnormality of 5q- was rarely seen in acute lymphoblastic leukemia. In such cases, the minimal deletion region overlaped between marks of D5S410 and D5S436 corresponding to chromosomal location 5q31-33. Conclusion 5q- is rare in acute lymphoblastic leukemia and more features are still to be found about the kind of disorder.
机构地区 [
出处 《白血病.淋巴瘤》 CAS 2012年第9期543-546,共4页 Journal of Leukemia & Lymphoma
关键词 白血病 双表型 急性 染色体缺失 Leukemia, biphenotypic, acute Chromasome deletion
  • 相关文献

参考文献19

  • 1冯宝章,雷健玲,刘焕勋,邵宗鸿,郝玉书.骨髓增生异常综合征染色体异常与白血病发展[J].白血病.淋巴瘤,2004,13(6):330-334. 被引量:6
  • 2邵英起,刘世和,徐世才,徐泽锋,李睿,邱录贵,郝玉书,肖志坚.261例急性髓系白血病的WHO分型[J].白血病.淋巴瘤,2005,14(3):129-132. 被引量:5
  • 3Patnaik MM, Lasho TL, Finke CM, et al. Isolated deI(Sq) in myeloid malignancies: clinicopathologic and molecular features in 143 consecutive patients. Am J Hematol, 2011, 86: 393-398.
  • 4Santana-Davila R, Hohan SG, Dewald GW, et al. Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution. Leuk Res, 2008, 32: 407- 411.
  • 5Theodossiou C, Scalise A, Troy K, et al. del(Sq) in acute lymphoblastic leukemia with biphenotypi~ and early progenitor phenotype. Cancer Genet Cytogenet, 1992, 63: 89-94.
  • 6Abe S, Kohno S, Kubonishi I, et al. Chromosomes and causation of human cancer and leukemia. XXXIII. 5q- in a case of acute lymphoblastic leukemia (ALL). Am J Hematol, 1979, 6: 259-266.
  • 7van den Berghe H, Cassiman JJ, David G, et al. Distinct haematological disorder with deletion of long arm of no. 5 chromosome. Nature, 1974, 251 : 437-438.
  • 8Giagounidis AA, Germing U, Aul C. Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies. Clin Cancer Res, 2006, 12: 5-10.
  • 9Kostrzewa M, Krings BW, Dixon M J, et al. Integrated physical and transcript map of 5q31-3-qter. Eur J Hum Genet, 1998, 6: 266-274.
  • 10Bouhwood J, Fidler C, Lewis S, et al. Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q-syndrome: delineation of the critical region on 5q and identification of a 5q-breakpoint. Genomics, 1994, 19: 425-432.

二级参考文献18

  • 1Kass L, Munster D. Thymidylate synthetase and serine transhydroxymethylase activities in preleukemic disorders of erythropoiesis and acute leukemia[J].Hematologica, 1980,65(2):196-203.
  • 2Luceioni C, Muleris M, Sabatier C, et al. Chromosomal and enzymatic patterns provide evidence for two types of human colon cancer with abnormal nucleotide metabolism[J]. Mut Res,1988,200:55-62.
  • 3Skibola C F, Smith M T, Hubbard A, et al. Polymorphisms in thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia [J]. Blood, 2002,99(10):3786-3791.
  • 4Demeshek W. Riddle:what do aplastic anemia, paroxysmalnocturnal hemo globinuria (PNH) and ""hypoplastic ""leukemia have in common?[J]. Blood, 1967,30:251.
  • 5March J C W, Geary C G. Annotation: Is AA a preleukemic disorder?[J]. Brit J Hematol, 1991, 77:447-452.
  • 6Young N S. Problem of clonality in AA:Dr Demeshek's Riddle,restated[J]. Blood, 1992,79(2):1385 - 1392.
  • 7Tichelli A, Gratwohl A, Nissen C, et al. Late clonal complication in severe aplastic anemia[J]. Leuk Lymphoma, 1994, 12:167.
  • 8Raskind W H, Steimann L, Najfeld V. Clonal development of myeloproliferative disorders: dues to hematopoietic differentiation and multstep pathogenesis of cancer[J]. Leukemia, 1998,12 (2): 108 -116.
  • 9Greenberg P, Cox C, Lebeau M, et al. International Scoring System for Evaluating Prognosis in MDS[J]. Blood, 1997, 89(6): 2079-2088.
  • 10Vardiman J W, Harris N L, Brunning R D. The World Health Organization(WHO) classification of the myeloid neoplasms[J]. Blood, 2002,100:2292-2302.

共引文献9

同被引文献10

  • 1Huguet F,Leguay T,Raffoux E,et al. Pediatric inspired therapy inadults with Philadelphia chromosome-negative acute lymphoblasticleukemia : the GRAALL / 2003 study [ J ]. J Clin Oncol, 2009,27(6): 911-918.
  • 2Kantarjian H, Thomas D, O'Brien S, et al. Long-term follow-upresults of hyperfractionated cyclophosphamide, vincristine,doxorubicin, and dexamethasone ( Hyper-CVAD ) , a dose-intensiveregimen,in adult acute lymphocytic leukemia [ J ]. Cancer,2004,101( 12) : 2788-2801.
  • 3Pui CH, Relling MV, Downing JR, et al. Acute lymphoblasticleukemia[J].N Engl J Med,2004,350( 15): 1535-1548.
  • 4Storring JM,Minden MD,Kao S,et al. Treatment of adult acutelymphoblastic leukaemia ( ALL) with a modified DFCI pediatricregimen [ J ]. Br J Haematol,2009,146 (1 ) : 76-85.
  • 5Stock W, La M, Sanford B, et al. What determines the outcomes foradolescents and young adults with acute lymphoblastic leukemiatreated on cooperative protocols. A comparison of Children's CancerGroup and Cancer and Leukemia Group B studies [ J ]. Blood,2008,112(5):1646-1674.
  • 6Ramanujachar R, Richards S, Hann I, et al. Adolescents with acutelymphoblastic leukaemia : outcome on UK national paediatric(ALL97 ) and adult ( UKALL XU / E2993 ) trials [ J ]. PediatrBlood Cancer, 2007, 48 ( 3 ) : 254-261.
  • 7Boissel N, Auclerc MF, Lheritier V, et al. Should adolescents withacute lymphoblastic leukemia be treated as old children or youngadults. Comparison of the French FRALLE-93 and LALA-94 trials[Jl.JClin Oncol, 2003, 21(5):774-780.
  • 8Ribera JM, Oriol A, Sanz MA, et al. Comparison of the results of thetreatment of adolescents and young adults with standard-risk acutelymphoblastic leukemia with the pediatric-based protocol PETHEMAALL-96[J].J Clin Oncol,2008,26(11); 1843-1849.
  • 9Kumar K,Kaur J, Walia S, et al. L-asparaginase: an effective agentin the treatment of acute lymphoblastic leukemia [ J ]. LeukLymphoma, 2014, 55 ( 2 ) : 256-262.
  • 10王婷婷,王昭,付丽,魏娜,黄达永,王晶石,沈晶,杨凌志,崔华,熊梅.改良Hyper—CVAD/MA方案治疗侵袭性淋巴瘤42例[J].白血病.淋巴瘤,2014,23(5):284-286. 被引量:1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部